Picard Medical, Inc. (PMI) income statement
PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3066% above fair value
$6.44−0.47 (-6.80%)
Close on Nov 18, 2026Market cap $15.06MP/E –Yield –
Picard Medical, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 26.2%
- Operating margin
- -267.2%
- Net margin
- -371.2%
- Return on equity, FY2025
- 134.3%
Financial strength
- Current ratio
- 0.99
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 0.9%
Valuation
- P/E ratio
- –
- Price to sales
- 2.83
- Price to book
- 11.32
- Dividend yield
- –
See a number that looks wrong?